Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $215.46 million for the year ending 2025.
- IRONWOOD PHARMACEUTICALS INC showed an increase of +143.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from IRONWOOD PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $35.36 million | Q3 2010: $58.70 million | Q1 2011: $46.21 million | Q2 2011: $48.19 million | Q3 2011: $68.82 million | Q1 2012: $131.61 million | Q2 2012: $87.08 million | Q3 2012: $125.87 million | Q1 2013: $105.30 million | Q2 2013: $219.46 million | Q3 2013: $144.45 million | Q1 2014: $205.13 million | Q2 2014: $95.36 million | Q3 2014: $51.27 million | Q1 2015: $63.69 million | Q2 2015: $256.45 million | Q3 2015: $248.08 million | Q1 2016: $280.93 million | Q2 2016: $277.33 million | Q3 2016: $182.94 million | Q1 2017: $133.32 million | Q2 2017: $182.13 million | Q3 2017: $162.64 million | Q1 2018: $144.79 million | Q2 2018: $145.42 million | Q3 2018: $141.56 million | Q1 2019: $119.05 million | Q2 2019: $98.91 million | Q3 2019: $139.23 million | Q1 2020: $231.14 million | Q2 2020: $253.25 million | Q3 2020: $307.56 million | Q1 2021: $438.47 million | Q2 2021: $492.70 million | Q3 2021: $574.28 million | Q1 2022: $593.37 million | Q2 2022: $504.37 million | Q3 2022: $574.19 million | Q1 2023: $740.34 million | Q2 2023: $175.32 million | Q3 2023: $110.16 million | Q1 2024: $121.54 million | Q2 2024: $105.52 million | Q3 2024: $88.21 million | Q1 2025: $108.48 million | Q2 2025: $92.85 million | Q3 2025: $140.41 million.
- Over the full 17 years of available data (2009 to 2025), IRONWOOD PHARMACEUTICALS INC's Cash And Cash Equivalents At Carrying Value has grown by 76.2%.
- Historical annual values: Fiscal year 2025: $215.46 million | Fiscal year 2024: $88.56 million | Fiscal year 2023: $92.15 million | Fiscal year 2022: $656.20 million | Fiscal year 2021: $620.13 million | Fiscal year 2020: $362.56 million | Fiscal year 2019: $177.02 million | Fiscal year 2018: $173.17 million | Fiscal year 2017: $125.74 million | Fiscal year 2016: $54.00 million | Fiscal year 2015: $261.29 million | Fiscal year 2014: $74.30 million | Fiscal year 2013: $75.49 million | Fiscal year 2012: $136.70 million | Fiscal year 2011: $87.28 million | Fiscal year 2010: $44.32 million | Fiscal year 2009: $122.31 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: